A rare autoimmune disease that can quietly extinguish a person's sight or movement has long resisted easy answers, leaving patients and clinicians to weigh uncertain odds against irreversible loss. Now, a meta-analysis drawing on a decade of clinical experience offers something rarer than a cure — a clearer path forward. Plasma exchange, a procedure that cleanses the blood of the rogue antibodies driving MOGAD's destruction, restored meaningful function in the vast majority of patients studied, with remarkably few complications. In medicine as in life, the most consequential discoveries are of
Plasma Exchange Shows Promise for Rare Nerve Disease That Causes Blindness
MOGAD can cause permanent blindness and paralysis if untreated, affecting patients' vision and mobility.